Age: 5.0
Sex: M
Vaccine: HEP, DTAP, HIBV, IPV, MMR
Symptoms: Mental retardation severity unspecified, Neurodevelopmental disorder, Psychomotor hyperactivity, Speech disorder
Clinical narrative: Initial report received from another manufacturer on 9/27/06, report number WAES0412USA03225. Information had been received by this reporter secondary to a case in litigation. Follow up information was received by the manufacturer from a health care professional via medical records, and the source was reported as confidential. An infant male who had four seemingly normal half sisters, had received a dose of IPOL, a fifth dose of ActHib and Tripedia (trade name Trihibit) and a second dose of another manufacturers MMR lot number 639571/1207L on 2/8/02. It was reported that, at an unspecified time, the pt had experienced toxic mercury exposure secondary to mercury emissions from power plants, the mercury in thimerosal laden products and via food chain. Per the report, minor male suffered serious and permanent neurological damage with associated learning disabilities, disorders and impairments. On an unreported date, the pt was diagnosed with developmental delay and autism features. The pt needed constant care and had daily living difficulties with dressing and bathing. The pts condition was stable and controlled with treatment (treatment was not reported). At one year of age, the pt had lead poisoning. The lead level was 10 on a whole blood lead test (1998), and no treatment was involved. The pt was evaluated by a physician on 10/5/01, at age four years old, for his developmental delay. His weight was 44 pounds, and his head circumference was 51 centimeters. The pt walked at 15 months. At that visit, it was noted the pt had a long standing history of ADHD. His first word was spoken at age four years. A hearing test was not performed due to the pt not being cooperative. The pt was assessed with developmental delay and autistic features. A special education program was strongly recommended. On 6/1/03 a hemoglobin and hematocrit test was completed but results were not reported. On 6/12/03, it was reported that the pt always had loose stools times 4 day, rule out mild intestine. Lab evaluation was completed for hemoglobin, hematocrit and whole blood lead test. The results were not reported. On 3/13/03, clinical evaluation revealed a childhood autism rating scale total score of 31, suggesting the pt had mild characteristics of autism in terms of overall development. The pt exhibited limited social and emotional skills and appeared cognitively deficient. It was recommended that the pt be within hand reach at all times or he would wander about without fear of the consequences of his behavior. Recommendations were made to have the pt involved in a highly structured environment with counseling and strict intervention behavioral plan. Diagnostic impressions were the following: pervasive developmental disorder, phonological disorder, ADHD, combined type, mixed receptive expressive language disorder, mild mental retardation, history speech and language delay, and a history of severe global developmental delays, psychosocial stressors, environmental problems, peer relations problems, academic problems, and severe developmental problems and global function. From follow up information received by the other manufacturer, as of 9/12/06, the pt was still having loose stools. The recovery status of the pt was reported as not recovered. Upon internal review, it was determined that autism, pervasive developmental disorder, and mild mental retardation were considered by the other manufacturer as important medical events. (OMIC).